Evaxion Biotech AS (EVAX)
1.37
-0.03
(-2.14%)
USD |
NASDAQ |
Nov 21, 16:00
1.37
0.00 (0.00%)
After-Hours: 20:00
Evaxion Biotech Price to Book Value: 108.60 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 108.60 |
| November 20, 2024 | 110.98 |
| November 19, 2024 | 123.66 |
| November 18, 2024 | 129.21 |
| November 15, 2024 | 114.15 |
| November 14, 2024 | 133.18 |
| November 13, 2024 | 139.52 |
| November 12, 2024 | 188.67 |
| November 11, 2024 | 191.84 |
| November 08, 2024 | 198.18 |
| November 07, 2024 | 207.69 |
| November 06, 2024 | 203.73 |
| November 05, 2024 | 206.90 |
| November 04, 2024 | 209.28 |
| November 01, 2024 | 205.31 |
| October 31, 2024 | 211.66 |
| October 30, 2024 | 218.79 |
| October 29, 2024 | 230.68 |
| October 28, 2024 | 225.13 |
| October 25, 2024 | 218.79 |
| October 24, 2024 | 210.07 |
| October 23, 2024 | 207.18 |
| October 22, 2024 | 198.65 |
| October 21, 2024 | 197.09 |
| October 18, 2024 | 204.85 |
| Date | Value |
|---|---|
| October 17, 2024 | 210.28 |
| October 16, 2024 | 210.28 |
| October 15, 2024 | 201.75 |
| October 14, 2024 | 208.73 |
| October 11, 2024 | 201.75 |
| October 10, 2024 | 204.08 |
| October 09, 2024 | 207.96 |
| October 08, 2024 | 220.37 |
| October 07, 2024 | 221.15 |
| October 04, 2024 | 228.91 |
| October 03, 2024 | 237.44 |
| October 02, 2024 | 231.24 |
| October 01, 2024 | 227.36 |
| September 30, 2024 | 241.32 |
| September 27, 2024 | 14.16 |
| September 26, 2024 | 13.88 |
| September 25, 2024 | 12.84 |
| September 24, 2024 | 13.22 |
| September 23, 2024 | 13.13 |
| September 20, 2024 | 13.31 |
| September 19, 2024 | 14.02 |
| September 18, 2024 | 13.89 |
| September 17, 2024 | 13.49 |
| September 16, 2024 | 14.47 |
| September 13, 2024 | 13.36 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.410
Minimum
Jun 17 2022
241.32
Maximum
Sep 30 2024
17.14
Average
4.832
Median
Price to Book Value Benchmarks
| Ascendis Pharma AS | -- |
| DBV Technologies SA | 0.869 |
| Adaptimmune Therapeutics PLC | 2.036 |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | 0.2315 |
Price to Book Value Related Metrics
| PS Ratio | 1.898 |
| Price | 1.37 |
| Earnings Yield | -204.4% |
| Market Cap | 8.037M |